News

Company News

Fast Track

Qilu Approved as “Export Innovation Base of Shandong Province”

ABOUT US

Company News

Fast Track

Qilu Approved as “Export Innovation Base of Shandong Province”

Release time：

2009-10-27

In September, Qilu was approved as “Export Innovation Base of Shandong Province” jointly by Department of Commerce and Science and Department of Technology of Shandong Province.

“Export Innovation Base of Shandong Province” is a very important platform for implementing the strategy of developing trade through science and technology, optimizing the export structure and products, enhancing capability of independent innovation and international competitive power. As a leading company in the pharmaceutical enterprises, Qilu successfully got the approval with its strong capability of innovation and high revenue in foreign trade.

It is reported that there are totally 12 export innovation bases being approved, covering various industries such as machinery, building materials, new energy, new materials, modern agriculture, biotechnology, new medicines, etc. “Export Innovation Base of Shandong Province” has access to Shandong provincial Government‘s support for the implementation of constructing the bases to improve the enterprises’ international competitiveness.

Qilu Pharma was Awarded As AAA Credit Rating

The 10th Swimming Competition Held

Related News

Qilu’s Ifosfamide for Injection Joins U.S. Shortage Drug Supply, Marking the 44th FDF Export to America

2026-08-28

Qilu First Prefilled Ranibizumab Biosimilar Coming to Canada

2026-08-26

Qilu Makes NDA Breakthrough in the U.S. Market

2026-06-30

Expanded Access Policy for QLS4131 for Injection

2025-10-13

Expanded Access Policy for QLS5133 for Injection